Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

AKBAAKBA
Showing 8 of 31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in AKEBIA THERAPEUTICS INC

Yes. Charles Schwab Investment Management holds 2,300,438 shares of AKBA (Akebia Therapeutics), worth $2.6M, as of its Q2 2026 13F filing. It increased the position by 284,861 shares (+14.1%) from Q1 2026. Charles Schwab Investment Management has held AKBA since Q3 2022, across 16 quarterly 13F filings.

Current Value

$2.6M

Current Shares

2.3M

Total Value Change

+$1.9M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+14.1%
$2.6M0.0%$1.14
30
2026-Q1
Decreased
2M
-7.6%
$2.8M0.0%$1.22
0
2025-Q4
Increased
2.2M
+0.5%
$3.5M0.0%$1.59
27
2025-Q3
Increased
2.2M
+189.8%
$5.9M0.0%$2.71
44
2025-Q2
Increased
749,015
+20.2%
$2.7M0.0%$3.65
31
2025-Q1
Increased
622,914
+6.2%
$1.2M0.0%$1.91
27
2024-Q4
Increased
586,710
+3.2%
$1.1M0.0%$1.85
26
2024-Q3
Decreased
568,667
-0.4%
$750,6400.0%$1.33
0

Other major holders of AKBA: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used